about
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesisRadiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsNMR structure and dynamics of recombinant wild type and mutated jerdostatin, a selective inhibitor of integrin α1β1Radiolabeled cyclic RGD peptides as radiotracers for tumor imagingThe role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfacesLigand conjugation to bimodal poly(ethylene glycol) brush layers on microbubbles.Smart Polymeric Gels: Redefining the Limits of Biomedical DevicesG-helix of maspin mediates effects on cell migration and adhesionDifferential effects of a soluble or immobilized VEGFR-binding peptide.2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokineticsSupramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repairFITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTAnti-angiogenic peptides for cancer therapeuticsNanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation.aV integrins and TGF-β-induced EMT: a circle of regulationRole of maspin in cancer.A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site.Differential regulation of angiogenesis using degradable VEGF-binding microspheres.The pharmacophore of a peptoid VEGF receptor 2 antagonist includes both side chain and main chain residues.Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkersImproving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkersRadiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.Phase II angiogenesis stimulators.Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists.A fluorescence polarization assay for identifying ligands that bind to vascular endothelial growth factor.Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cellsBioportide: an emergent concept of bioactive cell-penetrating peptides.Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.Structural investigation of the VEGF receptor interaction with a helical antagonist peptide.Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides
P2860
Q24318607-878812C0-F644-4D49-A276-B8B3AAF62F7AQ26801806-D065EFFF-1AFA-44FA-B873-BE53AD58E6ACQ27668187-6A89C614-CF10-4DFC-AA81-DE5E6B1CA4CBQ28072021-70DB414A-12C0-4C5C-8A26-B8CB21024744Q30464013-508D8EBF-526F-4F45-BF98-FE2FB602C832Q30474502-7947BCB4-4E1B-46FC-80B2-F8FCF4C23A75Q30493829-E3EFAAD3-E6CC-4F95-B8AD-BDA9A3A7EADBQ30497348-38B54084-FDF1-4B3D-B005-657C09A840E8Q30524090-9C2F910E-DD4E-469A-A563-CBD2CFE3C427Q33925952-8EA355A3-F258-4B8B-8393-BA9ACE275067Q34205393-FA1D8D29-43AD-4A76-8156-73A51BEED66AQ34556242-831DE4DA-A485-4BF0-B5DC-781BBA67DBE5Q34912643-1FD33209-52CF-4088-A577-15535DE6FAD1Q35043016-97793037-41E9-4E40-A9D6-127E975B3F5FQ35723548-AB2069C5-6AC1-4E42-B305-AE16B1642E25Q35791382-07B54829-A11E-4766-B4B6-7E72985E72C5Q36698729-F2C2C22F-6A1F-4576-9185-34D5501840DEQ36762954-AA7A782D-E31B-49C3-B0A8-C0196DC5108AQ36899777-5C1C41BA-4B3C-4568-96AA-944D732523A4Q36994025-8C0AB298-63D7-4FE6-8907-CA422FEED914Q37060623-A1292D06-8C6A-4CB5-98C3-2CC2B42B6357Q37081396-87D8198D-9E4D-4BBB-8C9E-F07F7695F186Q37178786-8D58C6A6-2953-45D3-8350-E9E12B3B22B8Q37480688-7F32B8B7-08C4-4FED-A4A2-E79F0BC6E94CQ37624526-18DE411B-765D-46BD-8204-11AECAF80EFBQ38116090-8D5650B8-E3EB-4B2B-AE6C-97B112E214EDQ38901081-ABBC3FF7-2E03-42C8-B2F9-C56C8A42144DQ41790733-2A5F6F6E-4A44-4289-8209-C8FEC14AB669Q42741722-FA571051-3B6B-44A7-8A2E-733078A8824FQ42979619-C7D11E8F-1199-46E8-BCD8-C7707032EB82Q53641809-A5409986-0155-41C6-8E41-4B3655E4B5A7Q54448798-B19444C2-B265-4E66-86E6-E9E652447C77Q57467572-4D8EE667-875C-4D17-A73B-44516655C6A6
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Peptide-based molecules in angiogenesis.
@ast
Peptide-based molecules in angiogenesis.
@en
type
label
Peptide-based molecules in angiogenesis.
@ast
Peptide-based molecules in angiogenesis.
@en
prefLabel
Peptide-based molecules in angiogenesis.
@ast
Peptide-based molecules in angiogenesis.
@en
P2093
P2860
P1476
Peptide-based molecules in angiogenesis.
@en
P2093
Annarita Del Gatto
Carlo Pedone
Ettore Benedetti
Luca Domenico D'Andrea
P2860
P304
P356
10.1111/J.1747-0285.2006.00356.X
P577
2006-02-01T00:00:00Z